A Nomogram for Individualized Frailty Identification in Older Inpatients with Schizophrenia: Development and Internal Validation

Objective: To investigate the prevalence and associated factors of frailty among older inpatients with schizophrenia, and to develop and internally validate a nomogram for individualized identification of current frailty. Methods: Between May and September 2025, we enrolled 279 older inpatients with schizophrenia (aged ≥ 60 years) from a tertiary hospital in Guangzhou using convenience sampling. Data included electronic medical records, patient interviews, and the Fried frailty phenotype assessment. Variables with univariate P < 0.1 or pre-specified clinical importance were refined by least absolute shrinkage and selection operator (LASSO) (10-fold cross-validation, lambda.1se) and binary logistic regression. A nomogram was built and internally validated using bootstrap (1,000 iterations). Performance was evaluated by the area under the receiver operating characteristic curve (AUC; DeLong’s method), calibration (Hosmer–Lemeshow test), and decision curve analysis (DCA). The study was approved by the Institutional Review Board of The Affiliated Brain Hospital of Guangzhou Medical University (Approval No: 2025– 034). Written informed consent was obtained from all participants or their legal guardians for those with impaired capacity. Results: Frailty prevalence was 38.0% (≥ 3 Fried criteria). Five clinical factors (represented by six variables) were retained: age (OR = 1.070, 95% CI: 1.018– 1.124), fall history (OR = 2.480, 95% CI: 1.027– 5.987), walking aid (OR = 4.021, 95% CI: 0.996– 16.228; borderline significance), sensory impairment (single: OR = 2.145, 95% CI: 1.051– 4.377; dual: OR = 3.470, 95% CI: 1.562– 7.708), and ADL (OR = 0.967, 95% CI: 0.936– 0.999). The model showed acceptable discrimination (AUC 0.767, 95% CI: 0.708– 0.826), good calibration (Hosmer–Lemeshow P = 0.552; Brier score 0.182; calibration slope 0.967). DCA showed positive net benefit at thresholds 0.1– 0.4. Conclusion: The nomogram showed acceptable discrimination and good calibration for identifying frailty in older inpatients with schizophrenia. Prospective multicenter external validation is needed. Keywords: schizophrenia, frailty, older adults, nomogram, identification

Authors

Institutions

Publication Details

Journal
Neuropsychiatric Disease and Treatment
Published
2026-10-31
DOI
https://doi.org/10.2147/ndt.s652910
Primary Topic
Frailty in Older Adults
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Nomogram for Individualized Frailty Identification in Older Inpatients with Schizophrenia: Development and Internal Validation

Xiulan Liu, Qiubi Tang, Chichen Zhang, Xiashu Yan et al.
Neuropsychiatric Disease and Treatment
Frailty in Older Adults
article

A Nomogram for Individualized Frailty Identification in Older Inpatients with Schizophrenia: Development and Internal Validation

Xiulan Liu, Qiubi Tang, Chichen Zhang, Xiashu Yan, Shuixian Yang, Tao Zheng, Xucong He, Huimin Zhou, Lexin Yuan, Cuixia Liu
article en

Abstract

Objective: To investigate the prevalence and associated factors of frailty among older inpatients with schizophrenia, and to develop and internally validate a nomogram for individualized identification of current frailty. Methods: Between May and September 2025, we enrolled 279 older inpatients with schizophrenia (aged ≥ 60 years) from a tertiary hospital in Guangzhou using convenience sampling. Data included electronic medical records, patient interviews, and the Fried frailty phenotype assessment. Variables with univariate P < 0.1 or pre-specified clinical importance were refined by least absolute shrinkage and selection operator (LASSO) (10-fold cross-validation, lambda.1se) and binary logistic regression. A nomogram was built and internally validated using bootstrap (1,000 iterations). Performance was evaluated by the area under the receiver operating characteristic curve (AUC; DeLong’s method), calibration (Hosmer–Lemeshow test), and decision curve analysis (DCA). The study was approved by the Institutional Review Board of The Affiliated Brain Hospital of Guangzhou Medical University (Approval No: 2025– 034). Written informed consent was obtained from all participants or their legal guardians for those with impaired capacity. Results: Frailty prevalence was 38.0% (≥ 3 Fried criteria). Five clinical factors (represented by six variables) were retained: age (OR = 1.070, 95% CI: 1.018– 1.124), fall history (OR = 2.480, 95% CI: 1.027– 5.987), walking aid (OR = 4.021, 95% CI: 0.996– 16.228; borderline significance), sensory impairment (single: OR = 2.145, 95% CI: 1.051– 4.377; dual: OR = 3.470, 95% CI: 1.562– 7.708), and ADL (OR = 0.967, 95% CI: 0.936– 0.999). The model showed acceptable discrimination (AUC 0.767, 95% CI: 0.708– 0.826), good calibration (Hosmer–Lemeshow P = 0.552; Brier score 0.182; calibration slope 0.967). DCA showed positive net benefit at thresholds 0.1– 0.4. Conclusion: The nomogram showed acceptable discrimination and good calibration for identifying frailty in older inpatients with schizophrenia. Prospective multicenter external validation is needed. Keywords: schizophrenia, frailty, older adults, nomogram, identification

Neuropsychiatric Disease and TreatmentVol. Volume 22
Southern Medical University (CN), Guangzhou Medical University (CN)
Openalex Percentile: Top 14%
Frailty in Older Adults
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon